Meeder Asset Management Inc Guardant Health, Inc. Transaction History

Meeder Asset Management Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$16.07 - $31.84 $1,285 - $2,547	80 New	80 $2,000
Q3 2022 Nov 14, 2022	SELL	$43.66 - $61.0 $130 - $183	-3 Reduced 75.0%	1 $0
Q2 2022 Aug 08, 2022	SELL	$28.82 - $77.35 $201 - $541	-7 Reduced 63.64%	4 $0
Q1 2022 May 10, 2022	BUY	$48.25 - $100.49 $530 - $1,105	11 New	11 $1,000
Q4 2021 Feb 11, 2022	SELL	$88.71 - $120.43 $4,612 - $6,262	-52 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$98.77 - $132.17 $5,728 - $7,665	-58 Reduced 52.73%	52 $7,000
Q2 2021 Aug 09, 2021	SELL	$109.77 - $165.68 $13,062 - $19,715	-119 Reduced 51.97%	110 $14,000
Q1 2021 Apr 28, 2021	BUY	$127.04 - $179.1 $26,170 - $36,894	206 Added 895.65%	229 $38,000
Q4 2020 Feb 09, 2021	BUY	$99.96 - $135.93 $99 - $135	1 Added 4.55%	23 $3,000
Q3 2020 Nov 02, 2020	SELL	$80.32 - $111.8 $6,827 - $9,503	-85 Reduced 79.44%	22 $2,000
Q2 2020 Aug 11, 2020	BUY	$60.49 - $97.5 $4,657 - $7,507	77 Added 256.67%	107 $9,000
Q1 2020 May 15, 2020	BUY	$59.04 - $88.81 $177 - $266	3 Added 11.11%	30 $2,000
Q4 2019 Feb 13, 2020	BUY	$59.49 - $82.78 $297 - $413	5 Added 22.73%	27 $2,000
Q3 2019 Oct 17, 2019	BUY	$62.59 - $110.3 $1,376 - $2,426	22 New	22 $1,000

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.59B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.